chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Muscle spasms, Pain
Clinical narrative: CRAMPS IN BOTH THIGHS; ACHY; TIRED; This spontaneous report received from a consumer concerned a 49 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included stroke (3x clot in brain), latex allergy, alcohol use, and nonsmoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 09-APR-2021 10:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 10-APR-2021, the subject experienced achy. On 10-APR-2021, the subject experienced tired. On 11-APR-2021, the subject experienced cramps in both thighs. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from cramps in both thighs, achy, and tired on 14-APR-2021. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction
Clinical narrative: UNSPECIFIED SIDE EFFECTS; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 13-APR-2021, the subject experienced unspecified side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of unspecified side effects was not reported. This report was non-serious.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Headache, Muscular weakness
Clinical narrative: MUSCLE WEAKNESS; NO ENERGY; TIRED; HEADACHE; LIGHT-HEADED; FACIAL SWELLING; This spontaneous report received from a patient concerned a 50 year old male. The patient's height, and weight were not reported. The patient's past medical history included covid- 19 infection.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978 and expiry: UNKNOWN) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 27-MAR-2021, the subject experienced facial swelling. On 29-MAR-2021, the subject experienced light-headed. On 29-MAR-2021, the subject experienced headache. On 30-MAR-2021, the subject experienced muscle weakness. On 30-MAR-2021, the subject experienced no energy. On 30-MAR-2021, the subject experienced tired. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from facial swelling on 02-APR-2021, was recovering from muscle weakness, and tired, and had not recovered from light-headed, headache, and no energy. This report was non-serious.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: MUSCLE WEAKNESS; NO ENERGY; TIRED; HEADACHE; LIGHT-HEADED; FACIAL SWELLING; This spontaneous report received from a patient concerned a 50 year old male. The patient's height, and weight were not reported. The patient's past medical history included covid- 19 infection.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978 and expiry: UNKNOWN) dose was not reported, administered on 27-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 27-MAR-2021, the subject experienced facial swelling. On 29-MAR-2021, the subject experienced light-headed. On 29-MAR-2021, the subject experienced headache. On 30-MAR-2021, the subject experienced muscle weakness. On 30-MAR-2021, the subject experienced no energy. On 30-MAR-2021, the subject experienced tired. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from facial swelling on 02-APR-2021, was recovering from muscle weakness, and tired, and had not recovered from light-headed, headache, and no energy. This report was non-serious.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, Pain, Productive cough, Pyrexia
Clinical narrative: PRESENCE OF PHLEGM; SORE THROAT; BODY ACHE; FEVER; HEADACHE; This spontaneous report received from a patient concerned a 22 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at the time of vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, and expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced presence of phlegm. On 06-APR-2021, the subject experienced sore throat. On 06-APR-2021, the subject experienced body ache. On 06-APR-2021, the subject experienced fever. On 06-APR-2021, the subject experienced headache. For phlegm, body ache, fever, headache, Sour throat patient visited to Doctor/healthcare professional office. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from presence of phlegm, body ache, fever, headache, and sore throat. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Sinus headache
Clinical narrative: HEADACHE SINUS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection, and headache. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, and batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced headache sinus. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from headache sinus. This report was non-serious.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Dyspnoea, Injection site induration, Pain in extremity
Clinical narrative: SHORTNESS OF BREATH; SHARP PAIN IN LEFT ABDOMEN; SHARP PAIN IN UPPER THIGH; HARDNESS AT INJECTION SITE; TENDER ARM; This spontaneous report received from a patient. The patient's height, and weight were not reported. The patient's concurrent conditions included lupus, fibromyalgia, and asthma. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: 09-JUN-2021) dose was not reported, administered on 29-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 29-MAR-2021, the subject experienced hardness at injection site. On 29-MAR-2021, the subject experienced tender arm. On APR-2021, the subject experienced sharp pain in left abdomen. On APR-2021, the subject experienced sharp pain in upper thigh. On an unspecified date, the subject experienced shortness of breath. Treatment medications (dates unspecified) included: hydrocodone bitartrate/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sharp pain in left abdomen, and sharp pain in upper thigh on 15-APR-2021, and had not recovered from tender arm, hardness at injection site, and shortness of breath. This report was non-serious.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysphagia, Fatigue, Head discomfort, Nerve compression
Clinical narrative: DIZZY; HEAVY HEAD; PINCHED NERVE IN THE NECK; LEFT LEG FEELS LIKE ITS ASLEEP; SLIGHT PROBLEM SWALLOWING; TIRED/FATIGUE; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported.  The patient's concurrent conditions included non alcohol user, and non smoker, and other pre-existing medical conditions included the patient had no known drug allergies. the patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 16:30 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced dizzy. On 08-APR-2021, the subject experienced heavy head. On 08-APR-2021, the subject experienced pinched nerve in the neck. On 08-APR-2021, the subject experienced left leg feels like its asleep. On 08-APR-2021, the subject experienced slight problem swallowing. On 08-APR-2021, the subject experienced tired/fatigue. Treatment medications (dates unspecified) included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizzy, heavy head, pinched nerve in the neck, left leg feels like its asleep, tired/fatigue, and slight problem swallowing. This report was non-serious.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: DIZZY; HEAVY HEAD; PINCHED NERVE IN THE NECK; LEFT LEG FEELS LIKE ITS ASLEEP; SLIGHT PROBLEM SWALLOWING; TIRED/FATIGUE; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported.  The patient's concurrent conditions included non alcohol user, and non smoker, and other pre-existing medical conditions included the patient had no known drug allergies. the patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 16:30 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced dizzy. On 08-APR-2021, the subject experienced heavy head. On 08-APR-2021, the subject experienced pinched nerve in the neck. On 08-APR-2021, the subject experienced left leg feels like its asleep. On 08-APR-2021, the subject experienced slight problem swallowing. On 08-APR-2021, the subject experienced tired/fatigue. Treatment medications (dates unspecified) included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizzy, heavy head, pinched nerve in the neck, left leg feels like its asleep, tired/fatigue, and slight problem swallowing. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea
Clinical narrative: PAIN BEHIND KNEE; SHORT OF BREATH; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On MAR-2021, the subject experienced short of breath. On 07-APR-2021, the subject experienced pain behind knee. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from pain behind knee, and the outcome of short of breath was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Feeling abnormal, Lethargy, Pyrexia, Retching
Clinical narrative: FELT AWFUL; FELT LETHARGIC; DRY HEAVES; FEVER OF 102.1; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced felt awful. On 08-APR-2021, the subject experienced felt lethargic. On 08-APR-2021, the subject experienced dry heaves. On 08-APR-2021, the subject experienced fever of 102.1. Laboratory data included: Body temperature (NR: not provided) 102.1 (unit not provided). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt awful, felt lethargic, dry heaves, and fever of 102.1 on APR-2021. This report was non-serious.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Injection site mass, Injection site pain
Clinical narrative: BODY ACHES; LUMP AT INJECTION SITE; CHILLS; JOINT PAIN; FEVER; HEADACHE; SWELLING AT INJECTION SITE; ARM PAIN AT INJECTION SITE; This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included seasonal allergies, and unspecified food allergy, and other pre-existing medical conditions included patient had not asked drug abuse or illicit drug usage, alcohol use and smoke. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1802068 expiry: 25-MAY-2021) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 25-MAR-2021, the subject experienced body aches. On 25-MAR-2021, the subject experienced lump at injection site. On 25-MAR-2021, the subject experienced chills. On 25-MAR-2021, the subject experienced joint pain. On 25-MAR-2021, the subject experienced fever. On 25-MAR-2021, the subject experienced headache. On 25-MAR-2021, the subject experienced swelling at injection site. On 25-MAR-2021, the subject experienced arm pain at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, joint pain, fever, headache, and arm pain at injection site on 28-MAR-2021, was recovering from swelling at injection site, and the outcome of lump at injection site was not reported. This report was non-serious.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Pain, Pyrexia
Clinical narrative: BODY ACHES; LUMP AT INJECTION SITE; CHILLS; JOINT PAIN; FEVER; HEADACHE; SWELLING AT INJECTION SITE; ARM PAIN AT INJECTION SITE; This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included seasonal allergies, and unspecified food allergy, and other pre-existing medical conditions included patient had not asked drug abuse or illicit drug usage, alcohol use and smoke. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1802068 expiry: 25-MAY-2021) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 25-MAR-2021, the subject experienced body aches. On 25-MAR-2021, the subject experienced lump at injection site. On 25-MAR-2021, the subject experienced chills. On 25-MAR-2021, the subject experienced joint pain. On 25-MAR-2021, the subject experienced fever. On 25-MAR-2021, the subject experienced headache. On 25-MAR-2021, the subject experienced swelling at injection site. On 25-MAR-2021, the subject experienced arm pain at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, joint pain, fever, headache, and arm pain at injection site on 28-MAR-2021, was recovering from swelling at injection site, and the outcome of lump at injection site was not reported. This report was non-serious.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Computerised tomogram, Fatigue, Headache, Insomnia
Clinical narrative: BODY ACHES; INSOMNIA; ENLARGED LYMPH NODE IN LEFT UNDERARM; TINGLING IN ARM; CHILLS; HEADACHE; FEVER; FATIGUE; MUSCLE SPASM; PAIN IN ARM; This spontaneous report received from a patient concerned a 66 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included pre existing arthritis. The patient experienced drug allergy when treated with hydrochlorothiazide/methyldopa, cefalexin, and diazepam. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, and batch number: 1808609 expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced muscle spasm. On APR-2021, the subject experienced pain in arm. Laboratory data included: CAT scan (NR: not provided) Pre-existing arthritis, and X-ray (NR: not provided) Pre-existing arthritis. On 01-APR-2021, the subject experienced body aches. On 01-APR-2021, the subject experienced insomnia. On 01-APR-2021, the subject experienced enlarged lymph node in left underarm. On 01-APR-2021, the subject experienced tingling in arm. On 01-APR-2021, the subject experienced chills. On 01-APR-2021, the subject experienced headache. On 01-APR-2021, the subject experienced fever. On 01-APR-2021, the subject experienced fatigue. On 14-APR-2021, Laboratory data included: Diagnostic ultrasound (NR: not provided) No problem in lymph node. Treatment medications (dates unspecified) included: paracetamol, and oxycodone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from insomnia on 13-APR-2021, chills, and headache, and fever on 06-APR-2021, was recovering from fatigue, had not recovered from body aches, and enlarged lymph node in left underarm, and the outcome of pain in arm, tingling in arm and muscle spasm was not reported. This report was non-serious.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Muscle spasms, Pain, Pain in extremity, Paraesthesia
Clinical narrative: BODY ACHES; INSOMNIA; ENLARGED LYMPH NODE IN LEFT UNDERARM; TINGLING IN ARM; CHILLS; HEADACHE; FEVER; FATIGUE; MUSCLE SPASM; PAIN IN ARM; This spontaneous report received from a patient concerned a 66 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included pre existing arthritis. The patient experienced drug allergy when treated with hydrochlorothiazide/methyldopa, cefalexin, and diazepam. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, and batch number: 1808609 expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced muscle spasm. On APR-2021, the subject experienced pain in arm. Laboratory data included: CAT scan (NR: not provided) Pre-existing arthritis, and X-ray (NR: not provided) Pre-existing arthritis. On 01-APR-2021, the subject experienced body aches. On 01-APR-2021, the subject experienced insomnia. On 01-APR-2021, the subject experienced enlarged lymph node in left underarm. On 01-APR-2021, the subject experienced tingling in arm. On 01-APR-2021, the subject experienced chills. On 01-APR-2021, the subject experienced headache. On 01-APR-2021, the subject experienced fever. On 01-APR-2021, the subject experienced fatigue. On 14-APR-2021, Laboratory data included: Diagnostic ultrasound (NR: not provided) No problem in lymph node. Treatment medications (dates unspecified) included: paracetamol, and oxycodone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from insomnia on 13-APR-2021, chills, and headache, and fever on 06-APR-2021, was recovering from fatigue, had not recovered from body aches, and enlarged lymph node in left underarm, and the outcome of pain in arm, tingling in arm and muscle spasm was not reported. This report was non-serious.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Ultrasound scan, X-ray
Clinical narrative: BODY ACHES; INSOMNIA; ENLARGED LYMPH NODE IN LEFT UNDERARM; TINGLING IN ARM; CHILLS; HEADACHE; FEVER; FATIGUE; MUSCLE SPASM; PAIN IN ARM; This spontaneous report received from a patient concerned a 66 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included pre existing arthritis. The patient experienced drug allergy when treated with hydrochlorothiazide/methyldopa, cefalexin, and diazepam. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, and batch number: 1808609 expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced muscle spasm. On APR-2021, the subject experienced pain in arm. Laboratory data included: CAT scan (NR: not provided) Pre-existing arthritis, and X-ray (NR: not provided) Pre-existing arthritis. On 01-APR-2021, the subject experienced body aches. On 01-APR-2021, the subject experienced insomnia. On 01-APR-2021, the subject experienced enlarged lymph node in left underarm. On 01-APR-2021, the subject experienced tingling in arm. On 01-APR-2021, the subject experienced chills. On 01-APR-2021, the subject experienced headache. On 01-APR-2021, the subject experienced fever. On 01-APR-2021, the subject experienced fatigue. On 14-APR-2021, Laboratory data included: Diagnostic ultrasound (NR: not provided) No problem in lymph node. Treatment medications (dates unspecified) included: paracetamol, and oxycodone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from insomnia on 13-APR-2021, chills, and headache, and fever on 06-APR-2021, was recovering from fatigue, had not recovered from body aches, and enlarged lymph node in left underarm, and the outcome of pain in arm, tingling in arm and muscle spasm was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Application site pain, Pain in extremity
Clinical narrative: ARM TENDERNESS TO THE TOUCH; ARM TENDERNESS; .This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced arm tenderness. On an unspecified date, the subject experienced arm tenderness to the touch. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from arm tenderness, and had not recovered from arm tenderness to the touch. This report was non-serious.
Age: 43.0
Sex: U
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Hyperhidrosis, Oropharyngeal pain
Clinical narrative: SWEATING; SORE THROAT; LIGHTHEADED; CHILLS; FEVER; HEADACHE; This spontaneous report received from a patient concerned a 43 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, treatment medications included: ibuprofen. On 10-APR-2021, the subject experienced headache. On 13-APR-2021, the subject experienced chills. On 13-APR-2021, the subject experienced fever. On 14-APR-2021, the subject experienced sweating. On 14-APR-2021, the subject experienced sore throat. On 14-APR-2021, the subject experienced lightheaded. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 14-APR-2021, was recovering from headache, and chills, and had not recovered from sweating, sore throat, and lightheaded. This report was non-serious.
Age: 43.0
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: SWEATING; SORE THROAT; LIGHTHEADED; CHILLS; FEVER; HEADACHE; This spontaneous report received from a patient concerned a 43 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, treatment medications included: ibuprofen. On 10-APR-2021, the subject experienced headache. On 13-APR-2021, the subject experienced chills. On 13-APR-2021, the subject experienced fever. On 14-APR-2021, the subject experienced sweating. On 14-APR-2021, the subject experienced sore throat. On 14-APR-2021, the subject experienced lightheaded. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 14-APR-2021, was recovering from headache, and chills, and had not recovered from sweating, sore throat, and lightheaded. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Platelet count decreased
Clinical narrative: DULL HEADACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included low platelet count.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 22-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced dull headache. Laboratory data (dates unspecified) included: Low platelets (NR: not provided) low blood count. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of dull headache was not reported. This report was non-serious.
Age: 39.0
Sex: U
Vaccine: COVID19
Symptoms: Skin mass
Clinical narrative: HARD LUMP ON HAND; This spontaneous report received from a consumer concerned a 39 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 15-APR-2021, the subject experienced hard lump on hand. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from hard lump on hand. This report was non-serious.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Choking sensation, Headache, Mucosal disorder, Muscle spasms
Clinical narrative: BOTH FEET SWOLLEN; GASSY/BLOATED FEELING; EXTREME HEADACHE; BOTH LEGS CRAMPING; THROAT CHOKING; MUCUS PRODUCTION FROM ALLERGY; SORE THROAT; This spontaneous report received from a patient concerned a 39 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcoholic, and non-smoker, and other pre-existing medical conditions included the patient had no known drug allergies. the patient had no drug abuse or illicit drug usage.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, treatment medications included: eucalyptus globulus oil/menthol. On 11-APR-2021, the subject experienced sore throat. On 11-APR-2021, the subject experienced mucus production from allergy. On 12-APR-2021, the subject experienced both legs cramping. On 12-APR-2021, the subject experienced throat choking. On 14-APR-2021, the subject experienced both feet swollen. On 14-APR-2021, the subject experienced gassy/bloated feeling. On 14-APR-2021, the subject experienced extreme headache. On 14-APR-2021 18:00, treatment medications included: acetylsalicylic acid. On 15-APR-2021 08:00, treatment medications included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from both legs cramping on APR-2021, sore throat, throat choking, and mucus production from allergy on 12-APR-2021, and both feet swollen, gassy/bloated feeling, and extreme headache on 15-APR-2021. This report was non-serious.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Peripheral swelling
Clinical narrative: BOTH FEET SWOLLEN; GASSY/BLOATED FEELING; EXTREME HEADACHE; BOTH LEGS CRAMPING; THROAT CHOKING; MUCUS PRODUCTION FROM ALLERGY; SORE THROAT; This spontaneous report received from a patient concerned a 39 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non-alcoholic, and non-smoker, and other pre-existing medical conditions included the patient had no known drug allergies. the patient had no drug abuse or illicit drug usage.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, treatment medications included: eucalyptus globulus oil/menthol. On 11-APR-2021, the subject experienced sore throat. On 11-APR-2021, the subject experienced mucus production from allergy. On 12-APR-2021, the subject experienced both legs cramping. On 12-APR-2021, the subject experienced throat choking. On 14-APR-2021, the subject experienced both feet swollen. On 14-APR-2021, the subject experienced gassy/bloated feeling. On 14-APR-2021, the subject experienced extreme headache. On 14-APR-2021 18:00, treatment medications included: acetylsalicylic acid. On 15-APR-2021 08:00, treatment medications included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from both legs cramping on APR-2021, sore throat, throat choking, and mucus production from allergy on 12-APR-2021, and both feet swollen, gassy/bloated feeling, and extreme headache on 15-APR-2021. This report was non-serious.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: CHILLS; This spontaneous report received from a patient concerned a 59 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included Tylenol allergy, non alcohol, and non smoker, and other pre-existing medical conditions included no food allergies, no drugs abuse. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 8105031, expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-APR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills. This report was non-serious.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: MIGRAINE; This spontaneous report received from a patient concerned a 50 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced migraine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from migraine. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Venous thrombosis
Clinical narrative: VENOUS THROMBOSIS; PAIN IN LEFT LEG; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. Frequency was 1 total. Vaccination site was unspecified. No concomitant medications were reported.  Batch number is not reported and has been requested. On 09-APR-2021, the patient experienced pain in left leg. On 16-APR-2021, he was diagnosed venous thrombosis, and  he was hospitalized (date unspecified). Consumer told that currently patient was admitted when she called. Treatment to treat adverse event was not reported. Hospital name and address was not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from venous thrombosis, and pain in left leg. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0:  This is a spontaneous report of a male of unspecified age who developed a venous thrombosis and was hospitalized 10 days after receiving the Janssen COVID-19 vaccine.  No medical history, concomitant medications or additional details were reported.  Additional information has been requested.  The case will be assessed further when additional information is received.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Severe dizziness went bending ormoving head and feelings of vertigo head down, 2 days after 2nd vaccination shot No rash, no swelling
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Injection site erythema, Mouth swelling, Pharyngeal swelling, Pruritus
Clinical narrative: Site: Redness at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Additional Details: pt reported slight swelling in throat but no trouble breathing, paramedics came and checked vitals and cleared, pt was monitored for an hour and given benadryl, symtoms went away and pt left
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Swollen tongue
Clinical narrative: Site: Redness at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Additional Details: pt reported slight swelling in throat but no trouble breathing, paramedics came and checked vitals and cleared, pt was monitored for an hour and given benadryl, symtoms went away and pt left
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Laboratory test, Rheumatoid arthritis
Clinical narrative: Rheumatoid arthritis pain greatly increased after the vaccine.
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pruritus, Rash
Clinical narrative: Itching and rash on chest, left neck and left cheek, leg pain mostly in left leg and occasionally in the right leg
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Additional Details: she became semi unresponsive, was dizzy and sat for atleast 45 minutes
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Muscle twitching, Pallor, Seizure like phenomena
Clinical narrative: Customer 30 seconds -1 minute after administration of the vaccine became unresponsive, and had facial twitching and overall body clenched down for 15 seconds--seizure like. Customer woke and assisted customer to ground, he reported lightheadedness, customer was pale. Customer was fasting. Customer reports within 5 minutes on the floor that he felt better. Assisted customer into sitting position and observed for 20 more minutes. customer reports being 100% at time of departure. Customer with his father.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Pallor
Clinical narrative: Client reported lightheadedness 4 minutes after vaccination.  Visibly pale.  Monitored by onsite EMS for 30 minutes.  Reported that he felt better.  Declined further monitoring.  Encouraged to follow up with PCP or emergency services if needed.  Verbalized understanding.  Driven off site by his mother.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Tachycardia
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Tachycardia-Mild, Additional Details: EMT was called.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time, Angiogram, Asthenia, Blood magnesium, Blood thyroid stimulating hormone
Clinical narrative: Per the member:  I received shot number 1 Moderna COIVD-19 vaccine on 27FEB21 at approximately 09:47 that morning. Had minor soreness on the injection site on my left arm. Rest of the day did not observe any adverse action. On 28FEB21 at around 12:15, I felt warm and flush. I assessed that my body was reacting to the the vaccine and that afternoon went to the unit aid station at the military compound I was located at and had a slight fever with a temperature of 99.1. I continued to hydrate, eat regular meals, work, and noticed now irregularities in body functions. Continued on page 2...
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram, Computerised tomogram head, Dizziness, Electrocardiogram, Feeling hot
Clinical narrative: Per the member:  I received shot number 1 Moderna COIVD-19 vaccine on 27FEB21 at approximately 09:47 that morning. Had minor soreness on the injection site on my left arm. Rest of the day did not observe any adverse action. On 28FEB21 at around 12:15, I felt warm and flush. I assessed that my body was reacting to the the vaccine and that afternoon went to the unit aid station at the military compound I was located at and had a slight fever with a temperature of 99.1. I continued to hydrate, eat regular meals, work, and noticed now irregularities in body functions. Continued on page 2...
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Flushing, Full blood count, Hemiparesis, Injection site pain, Lipids
Clinical narrative: Per the member:  I received shot number 1 Moderna COIVD-19 vaccine on 27FEB21 at approximately 09:47 that morning. Had minor soreness on the injection site on my left arm. Rest of the day did not observe any adverse action. On 28FEB21 at around 12:15, I felt warm and flush. I assessed that my body was reacting to the the vaccine and that afternoon went to the unit aid station at the military compound I was located at and had a slight fever with a temperature of 99.1. I continued to hydrate, eat regular meals, work, and noticed now irregularities in body functions. Continued on page 2...
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head, Metabolic function test, Paraesthesia, Prothrombin time, Pyrexia
Clinical narrative: Per the member:  I received shot number 1 Moderna COIVD-19 vaccine on 27FEB21 at approximately 09:47 that morning. Had minor soreness on the injection site on my left arm. Rest of the day did not observe any adverse action. On 28FEB21 at around 12:15, I felt warm and flush. I assessed that my body was reacting to the the vaccine and that afternoon went to the unit aid station at the military compound I was located at and had a slight fever with a temperature of 99.1. I continued to hydrate, eat regular meals, work, and noticed now irregularities in body functions. Continued on page 2...
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate, Sluggishness, Treponema test, Troponin, Visual impairment
Clinical narrative: Per the member:  I received shot number 1 Moderna COIVD-19 vaccine on 27FEB21 at approximately 09:47 that morning. Had minor soreness on the injection site on my left arm. Rest of the day did not observe any adverse action. On 28FEB21 at around 12:15, I felt warm and flush. I assessed that my body was reacting to the the vaccine and that afternoon went to the unit aid station at the military compound I was located at and had a slight fever with a temperature of 99.1. I continued to hydrate, eat regular meals, work, and noticed now irregularities in body functions. Continued on page 2...
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Vitamin B12
Clinical narrative: Per the member:  I received shot number 1 Moderna COIVD-19 vaccine on 27FEB21 at approximately 09:47 that morning. Had minor soreness on the injection site on my left arm. Rest of the day did not observe any adverse action. On 28FEB21 at around 12:15, I felt warm and flush. I assessed that my body was reacting to the the vaccine and that afternoon went to the unit aid station at the military compound I was located at and had a slight fever with a temperature of 99.1. I continued to hydrate, eat regular meals, work, and noticed now irregularities in body functions. Continued on page 2...
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Feeling cold, Feeling hot, Headache, Pain in extremity
Clinical narrative: head ach, sore arm, upset stomach fever, cold hot
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: head ach, sore arm, upset stomach fever, cold hot
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Flushing, Hypotension
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysphagia, Dyspnoea, Flushing, Hyperhidrosis
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hyperventilation-Mild, Additional Details: Patient was taken to local hospital
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperventilation, Throat tightness
Clinical narrative: Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hyperventilation-Mild, Additional Details: Patient was taken to local hospital
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Rash
Clinical narrative: Chills, rash
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Diarrhoea, Facial discomfort, Headache
Clinical narrative: Site: Pain at Injection Site-Severe, Systemic: Diarrhea-Mild, Systemic: Fever-Mild, Systemic: Headache-Medium, Systemic: Joint Pain-Medium, Systemic: Nausea-Mild, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Weakness-Medium
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Injection site pain, Nausea, Paraesthesia, Pyrexia
Clinical narrative: Site: Pain at Injection Site-Severe, Systemic: Diarrhea-Mild, Systemic: Fever-Mild, Systemic: Headache-Medium, Systemic: Joint Pain-Medium, Systemic: Nausea-Mild, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Systemic: Weakness-Medium
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Patient developed left-sided facial numbness approximately 25 hours post-vaccination. Numbness is on patient's left side, extends to midline of forehead, nose, chin, and includes left ear and left neck.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebral venous thrombosis, Computerised tomogram head, Computerised tomogram neck
Clinical narrative: CEREBRAL VEIN THROMBOSIS 3 WEEKS AFTER RECEIVING PZIZER VACCINATION
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too Low
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Pain, Pyrexia, Rash
Clinical narrative: Fever, body aches, rash, soft ball sized lump at injection site
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Beginning after 2nd shot, body rash and hives every 3 or 4 days.  Still happening.  Taking zyrtec
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Increase in tinnitus volume.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Back pain, Computerised tomogram normal, Headache, Nausea
Clinical narrative: Head aches, first the on 4/14 went to hospital for severe stomach and back pain which lasted about 6 Plus hours with nausea still had head ache for 2 more days. Had no insurance haven't had any problems before injection.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: patient is 14 and received the vaccine inadvertently. our clinic does not administer to any individuals under the age of 16. no issues to minor at this time.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Heart rate, Oxygen saturation, Pruritus, Rash
Clinical narrative: Itching at site of vaccine which was given left deltoid area which extend down to the thigh area.  Also rashes noted on both arms.  B/P 105/69, Heartrate 82, O2Sat 93.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Itching at site of vaccine which was given left deltoid area which extend down to the thigh area.  Also rashes noted on both arms.  B/P 105/69, Heartrate 82, O2Sat 93.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cold sweat, Dizziness, Dysphagia, Fall
Clinical narrative: Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient was sitting for 15 minute observation when I heard a thump outside. Came out to patient face down on the floor. Immediately woke up when I called out, but was unaware he had fainted. Gave patient water and gatorade and continued to monitor for 40 minutes. Patient continued to feel clammy and lightheaded but eventually felt okay to go home.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Syncope, Throat tightness, Unresponsive to stimuli
Clinical narrative: Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Chills-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient was sitting for 15 minute observation when I heard a thump outside. Came out to patient face down on the floor. Immediately woke up when I called out, but was unaware he had fainted. Gave patient water and gatorade and continued to monitor for 40 minutes. Patient continued to feel clammy and lightheaded but eventually felt okay to go home.